Sathan Raj Natarajan

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsNanomedicineBiologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 04, 2026
Integrated Bioinformatic and Experimental Analysis Reveals the Molecular Mechanisms Underlying KDM1B/LSD2 Inhibition as a Therapeutic Strategy in Human Lung Adenocarcinoma.

|Jul 02, 2025
Morin-Loaded Nanoalloy-Reduced Graphene Oxide Nanoplatforms for Synergetic Chemotherapy to Target Metastatic Triple-Negative Breast Cancer.

Prabu Kumar Seetharaman, Bo Liu, Ananth Sivapunniyam

|Apr 14, 2022
Diosgenin derivatives developed from Pd(II) catalysed dehydrogenative coupling exert an effect on breast cancer cells by abrogating their growth and facilitating apoptosis via regulating the AKT1 pathway.

S Dharani, G Kalaiarasi, M Ravi

|Jan 20, 2022
MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.

Lavanya Ponnusamy, Sathan Raj Natarajan, Ravi Manoharan

Pageof 1

Frequent Collaborators

2 joint publications

Ravi Manoharan

1 joint publications

G Kalaiarasi

1 joint publications

R Prabhakaran

1 joint publications

Lavanya Ponnusamy